neostigmine Methylsulfate, 1 mg per mL, 3 mg per 3 mL, 3 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3551.
Reason: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
D-0084-2017October 19, 2016Lake Forest, IL
Pharmedium Services, LLC
Class IITerminated
ketamine HCl Injection, 50 mg per mL (100 mg per 2 mL), 2 mL Total Volume in a syringe, Rx only, PharMEDium, For IV Use, Product code 2R3500.
Reason: Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.
D-0057-2017October 19, 2016Lake Forest, IL
Pharmedium Services, LLC
Class IITerminated
lidocaine HCl 2%, Preservative Free, 20 mg per mL (100 mg per 5 mL), 5 mL Total Volume in a syringe, Rx only, PharMEDium, Product code 2R3384.
Reason: Stability Data Does Not Support Expiry:potential loss of potency in drugs packaged and stored in syringes.
D-0067-2017October 19, 2016Lake Forest, IL
Lyne Laboratories, Inc.
Class IIITerminated
Cyproheptadine Hydrochloride Syrup, Oral Solution USP, 2 mg/5 mL, packaged in an amber glass 473 mL (one pint) bottle with child-resistant screw closure, Rx only, Distributed by: Rising Pharmaceutical...
Reason: Subpotency: product assayed and found OOS for cyproheptadine
D-1062-2016July 13, 2016Brockton, MA
Pharmakon Pharmaceuticals
Class ITerminated
Morphine Sulfate 0.5 mg/mL, Preservative Free in 0.9% Sodium Chloride, Rx, total volume 1 mL, This is a compounded drug, CII, IV Use, syringe, Pharmakon Pharmaceuticals, NDC 45183-0322-78.
Reason: Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.
D-0871-2016June 1, 2016Noblesville, IN
Akorn, Inc.
Class IIITerminated
IC-GREEN (indocyanine green for injection, USP), 25 mg Kit (NDC 17478-701-02, UPC 3 17478-701-02 6) containing 6-count IC-Green Vials 25 mg (NDC 17478-701-25, barcode (01)00317478701255) and 6-count 1...
Reason: Subpotent Drug: Low out-of-specification potency result of the drug product.
D-1429-2015September 23, 2015Lake Forest, IL
Boehringer Ingelheim Roxane Inc
Class IICompleted
Acarbose Tablets 50 mg a)10 x 10 Unit Dose Tablets per Blister Pack, b)100 count Bottles, Rx only, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC a) 0054-0141-20, b) 0054-0141-25
Reason: Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.
D-1085-2015June 3, 2015Columbus, OH
Baxter Healthcare Corp.
Class IITerminated
Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx only, Manufactured for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL...
Reason: Subpotent Drug: Heparin raw material was found to have low potency
D-0276-2015December 3, 2014Deerfield, IL
West-Ward Pharmaceutical Corp.
Class IITerminated
VERSAPHARM INCORPORATED Ethambutol Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx Only, Manufactured for VersaPharm Incorporated Marietta, GA 30065-1509 Manufactured by West-ward Pharmaceuti...
Reason: Subpotency: Out of Specification (OOS) result at the 36 month routine stability time point.
D-0172-2015November 5, 2014Eatontown, NJ
Independent Nutrition Center, Inc.
Class IITerminated
Red Yeast Rice High Potency Dietary Supplement, 600 mg, packaged in a) 120-count VegeCaps per bottle (UPC 8 01650 02205 9) and b) 500-count VegeCaps per bottle (UPC 8 01650 02206 6), Manufactured by: ...
Reason: Marketed Without An Approved NDA/ANDA: Product is being recalled due to excessive levels of lovastatin. Lovastatin is an FDA approved drug making this dietary supplement an unappro...
D-1349-2014May 28, 2014Eugene, OR
Medisca Inc.
Class ITerminated
Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regula...
Reason: Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.
D-1263-2014May 7, 2014Irving, TX
Actavis
Class IIITerminated
Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only. Physician sample in clamshell container with seven heat-sealed sachets. Rx Only. Watson Pharmaceuticals Inc, Coro...
Reason: Subpotent Drug: Drug potency was compromised during shipment.
D-1088-2014March 5, 2014Salt Lake City, UT
IQ Formulations, LLC
Class ITerminated
Hydravax High Potency Diuretic Weight Loss Solution, Pharmaceutical Grade, 45 capsules per bottle, Dietary Supplement, Manufactured and Distributed by Metabolic Nutrition, Sunrise, Florida, www.metabo...
Reason: Marketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic called Triamterene, an FDA approved prescription only medication used to...
D-1050-2014February 5, 2014Sunrise, FL
Fabscout Entertainment, Inc
Class ITerminated
72HP MAXIMUM POTENCY MALE SEXUAL ENHANCEMENT, Dietary Supplement, supplied in 1 capsule per blister pack, Distributed by: 72HP, Inc. Weston, FL
Reason: Marketed without an Approved NDA/ANDA: products were found to contain undeclared sildenafil
D-377-2014December 25, 2013Ft Lauderdale, FL
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b) 1000-count bottles (NDC 60793-854-10), Rx only, Manufactured and Distributed by: King ...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-425-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) 1000-count bottles (NDC 60793-851-10), Rx only, Manufactured and Distributed by: King P...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-422-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b) 1000-count bottles (NDC 60793-859-10), Rx only, Manufactured and Distributed by: King ...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-430-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b) 1000-count bottles (NDC 60793-858-10), Rx only, Manufactured and Distributed by: King ...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-429-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles (NDC 60793-856-10), Rx only, Manufactured and Distributed by: King ...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-427-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b) 1000-count bottles (NDC 60793-855-10), Rx only, Manufactured and Distributed by: King ...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-426-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) 1000-count bottles (NDC 60793-853-10), Rx only, Manufactured and Distributed by: King P...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-424-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) 1000-count bottles (NDC 60793-850-10), Rx only, Manufactured and Distributed by: King P...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-421-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b) 1000-count bottles (NDC 60793-852-10), Rx only, Manufactured and Distributed by: King P...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-423-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b) 1000-count bottles (NDC 60793-857-10), Rx only, Manufactured and Distributed by: King ...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.
D-428-2013May 29, 2013Bristol, TN
King Legacy, a wholly owned subsidiary of Pfizer
Class IITerminated
Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b) 1000-count bottles (NDC 60793-860-10), Rx only, Manufactured and Distributed by: King ...
Reason: Subpotent Drug: The products were below specification for potency at the expiry stability point.